Nuvation Bio (NUVB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Post Holdings (POST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But what's the best way ...

(BSET) on Wednesday reported fiscal second-quarter net income of $1.9 million, after reporting a loss in the same ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

CHICAGO (AP) — CHICAGO (AP) — Methode Electronics Inc. (MEI) on Wednesday reported a loss of $28.3 million in its fiscal fourth quarter. The Chicago-based company said it had a loss of 80 cents per ...

In the closing of the recent trading day, Enphase Energy (ENPH) stood at $40.94, denoting a -3.58% move from the preceding trading day.

For the most recent quarter, Northern Trust was expected to post earnings of $1.9 per share, but it reported $1.85 per share ...

Note: The following is an excerpt from this week’s Earnings Trends report. You can access the full report that contains ...

List today: Cronos Group Inc. CRON: This cannabinoid company has seen the Zacks Consensus Estimate for its current year ...